Abstract
The COVID-19 pandemic caused by SARS-CoV-2 has radically changed global healthcare. On May 13, 2020, all countries of the European Region reported their COVID-19 status, with 1 757 814 confirmed cases and 157 923 confirmed deaths.1 Each country has initiated measures to reduce the impact on healthcare systems and to mitigate the transmission of SARS-CoV-2. Suspension or postponement of all non-urgent diagnostic procedures and interventions were among the first adopted strategies to reduce the workload on healthcare facilities, while procedures for urgent or oncological cases have been maintained. Measures such as “social distancing”, defined as keeping distance between individuals outside of their home, and “lockdown”, defined as restricting the movement of the population except for necessity, work, and health circumstances, have been adopted extensively.
| Original language | English |
|---|---|
| Pages (from-to) | 1097-1100 |
| Number of pages | 4 |
| Journal | International Journal of Gynecological Cancer |
| Volume | 30 |
| Issue number | 8 |
| Early online date | 2 Jun 2020 |
| DOIs | |
| Publication status | Published - Aug 2020 |
Bibliographical note
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
https://bmj.com/coronavirus/usage
Keywords
- cervical cancer
